More articles from Article

Response of endothelial cells to a dual tyrosine kinase receptor inhibition combined with irradiation
Alexandre Bozec, Patricia Formento, Joseph Ciccolini, Raphaëlle Fanciullino, Laetitia Padovani, Xavier Murraciole, Jean-Louis Fischel, Gerard Milano

Molecular Cancer Therapeutics Dec 2005, 4 (12) 1962-1971; DOI: 10.1158/1535-7163.MCT-05-0108
Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor
Sun Yang, Kaikobad Irani, Susan E. Heffron, Frances Jurnak, Frank L. Meyskens

Molecular Cancer Therapeutics Dec 2005, 4 (12) 1923-1935; DOI: 10.1158/1535-7163.MCT-05-0229
Homozygous deletions of methylthioadenosine phosphorylase in human biliary tract cancers
Collins A. Karikari, Michael Mullendore, James R. Eshleman, Pedram Argani, Lorenzo M. Leoni, Shrikanta Chattopadhyay, Manuel Hidalgo, Anirban Maitra

Molecular Cancer Therapeutics Dec 2005, 4 (12) 1860-1866; DOI: 10.1158/1535-7163.MCT-05-0103
Targeting stathmin in prostate cancer
Sucharita J. Mistry, Alexander Bank, George F. Atweh

Molecular Cancer Therapeutics Dec 2005, 4 (12) 1821-1829; DOI: 10.1158/1535-7163.MCT-05-0215
A dityrosyl-diiron radical cofactor center is essential for human ribonucleotide reductases
Bingsen Zhou, Jimin Shao, Leila Su, Yate-Ching Yuan, Christina Qi, Jennifer Shih, Bixin Xi, Bernard Chu, Yun Yen

Molecular Cancer Therapeutics Dec 2005, 4 (12) 1830-1836; DOI: 10.1158/1535-7163.MCT-05-0273
Knockdown of the cytoprotective chaperone, clusterin, chemosensitizes human breast cancer cells both in vitro and in vivo
Alan So, Shannon Sinnemann, David Huntsman, Ladan Fazli, Martin Gleave

Molecular Cancer Therapeutics Dec 2005, 4 (12) 1837-1849; DOI: 10.1158/1535-7163.MCT-05-0178
Transcriptional targeting modalities in breast cancer gene therapy using adenovirus vectors controlled by α-lactalbumin promoter
Xiong Li, Jie Zhang, Huanling Gao, Edyta Vieth, Kyung-Hee Bae, Yan-Ping Zhang, Sang-Jin Lee, Sudhanshu Raikwar, Thomas A. Gardner, Gary D. Hutchins, Dale VanderPutten, Chinghai Kao, Meei-Huey Jeng

Molecular Cancer Therapeutics Dec 2005, 4 (12) 1850-1859; DOI: 10.1158/1535-7163.MCT-05-0167
Inhibition of phosphatidylinositol 3-kinase sensitizes ovarian cancer cells to carboplatin and allows adjunct chemotherapy treatment
Suzanne D. Westfall, Michael K. Skinner

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1764-1771; DOI: 10.1158/1535-7163.MCT-05-0192
Potentiation of the lethality of the histone deacetylase inhibitor LAQ824 by the cyclin-dependent kinase inhibitor roscovitine in human leukemia cells
Roberto R. Rosato, Jorge A. Almenara, Sonia C. Maggio, Peter Atadja, Ruth Craig, Julie Vrana, Paul Dent, Steven Grant

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1772-1785; DOI: 10.1158/1535-7163.MCT-05-0157
Subsieve-size agarose capsules enclosing ifosfamide-activating cells: a strategy toward chemotherapeutic targeting to tumors
Shinji Sakai, Kenji Kawabata, Shinji Tanaka, Norifumi Harimoto, Ichiro Hashimoto, Changjun Mu, Brian Salmons, Hiroyuki Ijima, Koei Kawakami

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1786-1790; DOI: 10.1158/1535-7163.MCT-05-0227

Main menu

User menu

Search

More articles from Article

Pages

Articles

Info for

About MCT